Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
2020 · JAMA · 2,344 citations
https://doi.org/10.1001/jama.2020.17023
N
Nicholas Heming
Inserm(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
105
Papers
5.8K
Citations
33
h-index
50
i10-index
Nicholas Heming is an academic researcher from Inserm. The author has contributed to research in topics: Intensive Care Unit Cognitive Disorders & Respiratory Support and Mechanisms & Sepsis Diagnosis and Treatment. The author has an h-index of 33, co-authored 90 publications.
ORCID: 0000-0002-4537-7595Papers by this author
worksEculizumab as an emergency treatment for adult patients with severe COVID-19 in the intensive care unit: A proof-of-concept study
2020 · EClinicalMedicine · 171 citations
https://doi.org/10.1016/j.eclinm.2020.100590
Neuroanatomy of sepsis-associated encephalopathy
2017 · Critical Care · 163 citations
https://doi.org/10.1186/s13054-017-1643-z
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
2022 · JAMA · 134 citations
https://doi.org/10.1001/jama.2022.23257
Value and mechanisms of EEG reactivity in the prognosis of patients with impaired consciousness: a systematic review
2018 · Critical Care · 110 citations
https://doi.org/10.1186/s13054-018-2104-z
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
2021 · Intensive Care Medicine · 96 citations
https://doi.org/10.1007/s00134-021-06448-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat